Company Overview

We, NeoGenesis, are a group of professionals in the autologous cell therapies and stem cell field. Focusing on both domestic and international market, we have been exporting our high-end therapeutic products and devices to Northern/Southern America, Africa, Eastern/Central Asia, and Europe, in as many as 84 countries worldwide.

Transactions
-
Response Time
>24h
Response rate
0%

Business type	Trading Company, Distributor/Wholesaler, Other	Country / Region	Seoul, South Korea
Main Products	UNiStation, Genesis PRP, Neo Thread Series, Regenovue Series, Beta Series	Total employees	11 - 50 People
Total Annual Revenue	US$5 Million - US$10 Million	Year established	2014
Certifications	-	Product Certifications(4)	CE, CE, CE, CE
Patents	-	Trademarks	-
Main Markets	South Asia 10.00% Southern Europe 10.00% Northern Europe 10.00%

TRADE CAPABILITIES

Main Markets & Product(s)

Main markets	Total Revenue(%)	Main Product(s)	Verified

South Asia	10.00%
Southern Europe	10.00%
Northern Europe	10.00%
Western Europe	10.00%
Eastern Asia	10.00%
Mid East	10.00%
Southeast Asia	10.00%
Eastern Europe	10.00%
Central America	6.00%
Domestic Market	5.00%
North America	3.00%
Oceania	2.00%
Africa	2.00%
South America	2.00%

Verified

Trade Ability

Language Spoken	English, Chinese, Arabic, Russian, Korean
No. of Employees in Trade Department	11-20 People
Average Lead Time	3
Total Annual Revenue	US$5 Million - US$10 Million

Business Terms

Accepted Delivery Terms	FOB, CFR, CIF, EXW, FAS, CIP, DEQ, DDP, DDU, Express Delivery, DAF, DES
Accepted Payment Currency	USD, EUR, CNY
Accepted payment methods	T/T, Credit Card, PayPal, Western Union
Nearest Port	Incheon Port